AZ PHARMA

Schaarbeek ·KBO/BCE: BE 0777.890.807

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	28-08-2025	28 d late	2025-00420691
31-12-2023	31-07-2024	06-11-2024	98 d late	2024-00531092
31-12-2022	31-07-2023	31-12-2023	153 d late	2024-00543016

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.46M
Fixed assets	21/28	€1.46M
Tangible fixed assets	22/27	€356k
Financial fixed assets	28	€1.10M
Current assets	29/58	€2k
Cash & bank	54/58	€2k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.46M
Equity	10/15	€25k
Contributions / capital	10/11	€14k
Accumulated profits (losses)	14	€11k
Amounts payable	17/49	€1.43M
Amounts payable after one year	17	€628k
Amounts payable within one year	42/48	€805k
Trade debts payable within one year	44	€3k
Income statement
Gross operating margin	9900	€8k
Operating result	9901	€8k
Financial income	75	€115k
Financial charges	65	€27k
Result before taxes	9903	€96k
Net result for the period	9904	€96k
Result to be appropriated	9905	€96k

Summary